Literature DB >> 2316714

Triggering of erythropoietin production by hypoxia is inhibited by respiratory and metabolic acidosis.

K U Eckardt1, A Kurtz, C Bauer.   

Abstract

Erythropoietin (EPO) production in response to hypoxic hypoxia is known to be attenuated by simultaneous hypercapnia. This study aimed to investigate whether this inhibitory effect of hypercapnia is 1) a direct effect of carbon dioxide or mediated by changes in pH or bicarbonate, 2) affects also carbon monoxide hypoxia, and 3) influences either the synthesis and release of EPO or the mechanisms by which hypoxia triggers an increase in EPO production rate. We found that EPO formation in mice exposed to normobaric hypoxia (8% O2) or to carbon monoxide (0.1%) was reduced by 30 and 42% when animals were simultaneously exposed to hypercapnia (7% CO2), by 35 and 38% when subjected to metabolic acidosis (NH4Cl), and unchanged when subjected to metabolic alkalosis (NaHCO3). In animals exposed to brief hypoxia (15 min) and subsequent normoxia (2 h), metabolic acidosis did not affect EPO levels when initiated after the hypoxic period. The results indicate that acidosis inhibits hypoxia-induced triggering of EPO formation independently of PCO2 and HCO3 levels. Because this inhibitory effect is also present during carbon monoxide hypoxia, it appears not solely due to potentiated hyperpnea. Alternatively, it may result from a facilitated intrarenal oxygen release or a direct effect at the EPO production sites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316714     DOI: 10.1152/ajpregu.1990.258.3.R678

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  German Physiology Society. Abstracts of the Spring Meeting (69th Meeting). 5-8 March 1991, Freiburg.

Authors: 
Journal:  Pflugers Arch       Date:  1991       Impact factor: 3.657

2.  Effects of intermittent hypoxic training on cycling performance in well-trained athletes.

Authors:  Belle Roels; David J Bentley; Olivier Coste; Jacques Mercier; Grégoire P Millet
Journal:  Eur J Appl Physiol       Date:  2007-07-17       Impact factor: 3.078

3.  Inconsistent effects of acidosis on HIF-alpha protein and its target genes.

Authors:  Carsten Willam; Christina Warnecke; Jörg C Schefold; Jan Kügler; Petra Koehne; Ulrich Frei; Michael Wiesener; Kai-Uwe Eckardt
Journal:  Pflugers Arch       Date:  2005-10-06       Impact factor: 3.657

4.  Effects of physical training in a hypobaric chamber on the physical performance of competitive triathletes.

Authors:  J M Vallier; P Chateau; C Y Guezennec
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 5.  The effect of altitude on cycling performance: a challenge to traditional concepts.

Authors:  A G Hahn; C J Gore
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

6.  Human erythropoietin response to hypocapnic hypoxia, normocapnic hypoxia, and hypocapnic normoxia.

Authors:  T Klausen; H Christensen; J M Hansen; O J Nielsen; N Fogh-Andersen; N V Olsen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

7.  Perioperative plasma erythropoietin levels in hip arthroplasty.

Authors:  A Lorentz; K U Eckardt; P M Osswald; C Kruse
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

8.  Diurnal variations of serum erythropoietin at sea level and altitude.

Authors:  T Klausen; T D Poulsen; N Fogh-Andersen; J P Richalet; O J Nielsen; N V Olsen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

9.  The effect of short and long duration exercise on serum erythropoietin concentrations.

Authors:  T Klausen; L Breum; N Fogh-Andersen; P Bennett; E Hippe
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

10.  Hypercapnia Suppresses the HIF-dependent Adaptive Response to Hypoxia.

Authors:  Andrew C Selfridge; Miguel A S Cavadas; Carsten C Scholz; Eric L Campbell; Lynn C Welch; Emilia Lecuona; Sean P Colgan; Kim E Barrett; Peter H S Sporn; Jacob I Sznajder; Eoin P Cummins; Cormac T Taylor
Journal:  J Biol Chem       Date:  2016-04-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.